A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes.

Markus Riegersperger Max Plischke Anita Jallitsch-Halper Corinna Steinhauser Manuela Födinger Wolfgang C Winkelmayer Daniela Dunkler Gere Sunder-Plassmann

PLoS One

Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Austria, Europe.

Published: February 2020

PEP Study: Ethics committee N° 393/2004, EudraCT 2004-004209-98. PEP-X Study: Ethics committee amendment application N° 154/01/2008. ClinicalTrials.gov NCT03751332.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606311	PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0218709	PLOS

Publication Analysis

Top Keywords

study ethics

ethics committee

non-randomized trial

trial conversion

conversion ciclosporin

ciclosporin tacrolimus

tacrolimus tacrolimus

tacrolimus mr4

mr4 stable

stable long-term

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!